Porras M, Hernandez D, Boto A
Int J Mol Sci. 2025; 26(5).
PMID: 40076526
PMC: 11900302.
DOI: 10.3390/ijms26051900.
Oldham K, Jiao W, Prentice E, Hicks J
Comput Struct Biotechnol J. 2025; 27:682-691.
PMID: 40070520
PMC: 11894326.
DOI: 10.1016/j.csbj.2025.02.015.
McDonald M, Koscher B, Canty R, Zhang J, Ning A, Jensen K
ACS Cent Sci. 2025; 11(2):346-356.
PMID: 40028358
PMC: 11869128.
DOI: 10.1021/acscentsci.4c01991.
Mozaffari S, Moen A, Ng C, Nicolaes G, Wichapong K
Res Pract Thromb Haemost. 2025; 9(1):102691.
PMID: 40027444
PMC: 11869865.
DOI: 10.1016/j.rpth.2025.102691.
Porras M, Hernandez D, Boto A
Int J Mol Sci. 2025; 26(4).
PMID: 40004238
PMC: 11855090.
DOI: 10.3390/ijms26041775.
Novel 5,6-dichlorobenzimidazole derivatives as dual BRAF and BRAF inhibitors: design, synthesis, anti-cancer activity and molecular dynamics simulations.
Temirak A, El Kerdawy A, Nageeb A, Abdel-Mohsen H
BMC Chem. 2025; 19(1):45.
PMID: 39985108
PMC: 11844072.
DOI: 10.1186/s13065-025-01402-8.
Computational exploration in search for novel natural product-derived EZH2 inhibitors for advancing anti-cancer therapy.
Shyamal S
Mol Divers. 2025; .
PMID: 39969739
DOI: 10.1007/s11030-025-11128-3.
Heterocyclic core modifications in trypanosomacidal 2-[(phenylheteroaryl)ethyl]ureas.
Toynton A, Ferrins L, Newson H, Sykes M, Varghese S, Nguyen N
RSC Med Chem. 2025; .
PMID: 39967782
PMC: 11832035.
DOI: 10.1039/d4md00764f.
Virtual fragment screening for DNA repair inhibitors in vast chemical space.
Luttens A, Vo D, Scaletti E, Wiita E, Almlof I, Wallner O
Nat Commun. 2025; 16(1):1741.
PMID: 39966348
PMC: 11836371.
DOI: 10.1038/s41467-025-56893-9.
Discovery of novel covalent stabilizers for p53 Y220C using structure-based drug discovery methods.
Wen Y, Xu P, Chen Y, Meng J, Zheng M, Zhang S
Mol Divers. 2025; .
PMID: 39946082
DOI: 10.1007/s11030-024-11095-1.
Molecular Dynamics-Assisted Discovery of Novel Phosphodiesterase-5 Inhibitors Targeting a Unique Allosteric Pocket.
Luo W, Liu R, Cai X, Zhou Q, Zhang C
Molecules. 2025; 30(3).
PMID: 39942691
PMC: 11820102.
DOI: 10.3390/molecules30030588.
Optimizing Therapeutics for Intratumoral Cancer Treatments: Antiproliferative Vanadium Complexes in Glioblastoma.
Bates A, Klugh K, Galaeva A, Patch R, Manganaro J, Markham S
Int J Mol Sci. 2025; 26(3).
PMID: 39940763
PMC: 11817060.
DOI: 10.3390/ijms26030994.
Selective inhibitors of the TrkC.T1 receptor reduce retinal inflammation and delay neuronal death in a model of retinitis pigmentosa.
Brahimi F, Nassour H, Galan A, Guruswamy R, Ortiz C, Nejatie A
PNAS Nexus. 2025; 4(2):pgaf020.
PMID: 39911316
PMC: 11795507.
DOI: 10.1093/pnasnexus/pgaf020.
Machine learning-based screening and molecular simulations for discovering novel PARP-1 inhibitors targeting DNA repair mechanisms for breast cancer therapy.
Shahab M, Waqas M, Fahira A, Sharma B, Zhang H, Zheng G
Mol Divers. 2025; .
PMID: 39899126
DOI: 10.1007/s11030-025-11119-4.
A series of benzensulfonamide derivatives as new potent carbonic anhydrase IX and XII inhibitors.
Nencetti S, Cuffaro D, Ciccone L, Nocentini A, Di Stefano M, Poli G
Future Med Chem. 2025; 17(3):271-285.
PMID: 39878534
PMC: 11792798.
DOI: 10.1080/17568919.2025.2453420.
Docking 14 million virtual isoquinuclidines against the mu and kappa opioid receptors reveals dual antagonists-inverse agonists with reduced withdrawal effects.
Vigneron S, Ohno S, Braz J, Kim J, Kweon O, Webb C
bioRxiv. 2025; .
PMID: 39868130
PMC: 11760775.
DOI: 10.1101/2025.01.09.632033.
Virtual screening: hope, hype, and the fine line in between.
Nada H, Meanwell N, Gabr M
Expert Opin Drug Discov. 2025; 20(2):145-162.
PMID: 39862145
PMC: 11844436.
DOI: 10.1080/17460441.2025.2458666.
Rescue of Mutant CFTR Channel Activity by Investigational Co-Potentiator Therapy.
Bacalhau M, Ferreira F, Azevedo M, Rosa T, Buarque C, Lopes-Pacheco M
Biomedicines. 2025; 13(1).
PMID: 39857666
PMC: 11762957.
DOI: 10.3390/biomedicines13010082.
Enhancement of Cognitive Benefits and Anti-Anxiety Effects of Fruits in a Zebrafish () Model of Scopolamine-Induced Memory Impairment.
Popovici L, Brinza I, Gatea F, Badea G, Vamanu E, Oancea S
Antioxidants (Basel). 2025; 14(1).
PMID: 39857431
PMC: 11762548.
DOI: 10.3390/antiox14010097.
Synthesis, characterization, and computational evaluation of some synthesized xanthone derivatives: focus on kinase target network and biomedical properties.
Muslim W, Mohammad L, Naji M, Karimi I, Al-Sabti M, Jabir M
Front Pharmacol. 2025; 15():1511627.
PMID: 39830340
PMC: 11738930.
DOI: 10.3389/fphar.2024.1511627.